209 related articles for article (PubMed ID: 25670215)
1. Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts.
Park JK; Al-Tariq QZ; Zaw TM; Raman SS; Lu DS
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1211-7. PubMed ID: 25670215
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts.
Padia SA; Chewning RH; Kogut MJ; Ingraham CR; Johnson GE; Bhattacharya R; Kwan SW; Monsky WL; Vaidya S; Hippe DS; Valji K
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):913-21. PubMed ID: 25373795
[TBL] [Abstract][Full Text] [Related]
3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
5. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt.
Yan J; Ying X; Malhotra A; Talenfeld A; Charalel R; Lee KS; Trost D; Kesselman A
Cardiovasc Intervent Radiol; 2022 May; 45(5):578-581. PubMed ID: 34859308
[TBL] [Abstract][Full Text] [Related]
7. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Qiu B; Li K; Dong X; Liu FQ
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
[TBL] [Abstract][Full Text] [Related]
8. Transjugular Intrahepatic Portosystemic Shunt Creation Using a Radiofrequency Wire: Prospective Clinical Safety and Feasibility Trial in Cirrhosis.
Farsad K; Narasimhan E; Russell L; Kaufman JA
J Vasc Interv Radiol; 2020 Sep; 31(9):1401-1407. PubMed ID: 32792278
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
10. The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer.
Wong K; Ozeki K; Kwong A; Patel BN; Kwo P
PLoS One; 2018; 13(12):e0208233. PubMed ID: 30592722
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
[TBL] [Abstract][Full Text] [Related]
12. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
13. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
Balducci D; Montori M; De Blasio F; Di Bucchianico A; Argenziano ME; Baroni GS; Scarpellini E
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374354
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
[TBL] [Abstract][Full Text] [Related]
15. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L
Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983
[TBL] [Abstract][Full Text] [Related]
17. Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma: A preliminary study.
Dong H; Zhang C; Li Z; Yang H; Wang Y; Liu J; Liu B; Mao S
J Cancer Res Ther; 2021 Jul; 17(3):784-789. PubMed ID: 34269314
[TBL] [Abstract][Full Text] [Related]
18. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
